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Abstract 
 
Hydrogen sulphide (H2S) is a newly discovered gasotransmitter that regulates multiple steps in 
VEGF-induced angiogenesis. An increase in intracellular Ca2+ concentration ([Ca2+]i) is central to 
endothelial proliferation and may be triggered by both VEGF and H2S. Albeit VEGFR-2 might serve as 
H2S receptor, the mechanistic relationship between VEGF- and H2S-induced Ca2+ signals in endothelial 
cells is unclear. The present study aimed at assessing whether and how NaHS, a widely employed H2S 
donors, stimulates pro-angiogenic Ca2+ signals in Ea.hy926 cells, a suitable surrogate for mature 
endothelial cells, and human endothelial progenitor cells (EPCs). We found that NaHS induced a dose-
dependent increase in [Ca2+]i in Ea.hy926 cells. NaHS-induced Ca2+ signals in Ea.hy926 cells did not 
require extracellular Ca2+ entry, while they were inhibited upon pharmacological blockade of the 
phosholipase C/inositol-1,4,5-trisphosphate (InsP3) signalling pathway. Moreover, the Ca2+ response to 
NaHS was prevented by genistein, but not by SU5416, which selectively inhibits VEGFR-2. However, 
VEGF-induced Ca2+ signals were suppressed by DL-propargylglycine (PAG), which blocks the H2S-
producing enzyme, cystathionine γ-lyase. Consistent with these data, VEGF-induced proliferation and 
migration were inhibited by PAG in Ea.hy926 cells, albeit NaHS alone did not influence these 
processes. Conversely, NaHS elevated [Ca2+]i only in a modest fraction of circulating EPCs, whereas 
neither VEGF-induced Ca2+ oscillations nor VEGF-dependent proliferation were affected by PAG. 
Therefore, H2S-evoked elevation in [Ca2+]i is essential to trigger the pro-angiogenic Ca2+ response to 
VEGF in mature endothelial cells, but not in their immature progenitors. 
 
Keywords: HUVECs, endothelial progenitor cells, hydrogen sulphide, Ca2+ release, DL-
propargylglycine, proliferation 
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1.1 Introduction 
 
Hydrogen sulphide (H2S) is the latest entry in the growing family of gasotransmitters, already 
including nitric oxide (NO) and carbon monoxide (CO), that can be released by vascular endothelium 
to regulate cardiovascular functions [1, 2]. Endothelial H2S is synthesized from either L-cysteine or 
cystathionine by the pyridoxal-5′-phosphate-dependent enzyme cystathionine γ-lyase (CSE), which is 
absent in adjoining vascular smooth muscle cells [3]. It remains to be elucidated whether endothelial 
cells impinge on the intracellular pool of sulfur that liberates H2S in rodent neurons and astrocytes in 
the presence of physiologic levels of endogenous reducing substances, such as glutathione and cysteine 
[4]. Endothelial-derived H2S has been shown to regulate a myriad of processes within the 
cardiovascular system [1-3]. For instance, H2S affords cardioprotection against the 
ischemia/reperfusion injury by engaging both protein kinase C (PKC) and the phosphatidylinositol 3-
kinase (PI3-K)/Akt signaling pathway [5-7]. Moreover, H2S induces vasorelaxation in small resistance 
arteries by activating ATP-dependent K+ channels or intermediate- and small-conductance 
KCa (IKCa and SKCa) channels to hyperpolarize smooth muscle fibres, thereby reducing the vascular 
tone [8, 9]. Similar to NO and CO, H2S exerts an auto/paracrine action on the innermost layer of blood 
vessels, by regulating a wide range of endothelial functions. These include protection from apoptosis 
[10] and oxidative stress [11], defense against hypoxia-induced injury [12], delay of cell senescence 
[13], and inhibition of leukocyte adhesion and rolling [14, 15]. A recent series of studies has further 
demonstrated that sodium hydrosulfide (NaHS), a widely employed H2S donor, stimulates endothelial 
cell proliferation and tube formation both in vitro and in vivo [16-19]. NaHS-liberated H2S induces 
human umbilical vein ECs (HUVECs) to replicate and assembly into a three-dimensional capillary-like 
network when plated on Matrigel [20]. Consistently, the intraperitoneal injection of NaHS restores 
regional tissue blood flow in a rodent model of hind limb ischemia [17]. H2S stimulates HUVEC 
proliferation by enhancing the phosphorylation of Akt, extracellular signal-related kinase (ERK) and 
p38 [20]. The pro-angiogenic role of H2S is corroborated by the evidence that VEGF signalling is 
suppressed by the genetic/pharmacological ablation of CSE and that H2S is generated in response to 
VEGF stimulation [20, 21]. In addition, exogenous H2S administration may increase both the hypoxic 
tissue levels of VEGF [22] and the extent of VEGFR-2 activation in endothelial cells, thereby 
sustaining blood vessel regrowth after an ischemic insult [17]. VEGFR-2 is the most important receptor 
sustaining VEGF-induced mitogenesis, motility and tubulogenesis [23, 24]. Apart from VEGF binding, 
VEGFR-2 phosphorylation in HUVECs is induced by H2S-induced breaking of the disulfide bond 
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between Cys1045 and Cys1024, which leads to the recruitment of the PI3-K/Akt signalling pathway 
[18]. Therefore, VEGFR-2 might serve as the long-sought H2S receptor, albeit these data require 
further experimental challenge. 
An increase in intracellular Ca2+ concentration ([Ca2+]i) is a key event in the complex molecular 
network driving endothelial cell proliferation, migration and tubulogenesis [25-29]. For instance, both 
inositol-1,4,5-trisphosphate (InsP3)-dependent Ca2+ release and store-operated Ca2+ entry (SOCE) are 
recruited by VEGF to stimulate HUVEC proliferation and migration in in vitro angiogenic settings [27, 
30, 31]. Recent work from our group has unveiled that NaHS elevates [Ca2+]i in rat aortic endothelium 
by activating the forward mode (3 Na+ out : 1 Ca2+ in) of the Na+/Ca2+ exchanger (NCX), while it 
inhibits inositol-1,4,5-trisphosphate (InsP3)-dependent Ca2+ release and SOCE [32]. Similarly, H2S 
elicits Ca2+ entry in human breast carcinoma (B-TECs) upon the recruitment of a non-selective cation 
channel that mediates both cell migration and the concomitant Ca2+ response to VEGF [21]. VEGF-
induced Ca2+ signals and B-TEC motility are abrogated when CSE is inhibited with DL-
propargylglycine (PAG) [21]. It is, however, still unknown whether H2S targets VEGFR-2 to generate 
intracellular Ca2+ waves [4]. 
The present investigation aimed at assessing whether and how H2S evokes an increase in [Ca2+]i 
in two widely employed cellular models to study human endothelial signaling: human umbilical vein-
derived EA.hy926 cells, which are an established model to study in vitro angiogenesis in mature 
endothelium [30], and human endothelial progenitor cells (EPCs), which are committed to acquire a 
mature endothelial phenotype once released into peripheral circulation [24]. We demonstrated that H2S 
elicits robust intracellular Ca2+ signals in Ea.hy926 cells, but not in EPCs. The Ca2+ response to H2S in 
fully differentiated endothelial cells depends on Ca2+ mobilization from InsP3-sensitive stores and 
independent on extracellular Ca2+ inflow. However, the pharmacological blockade of VEGFR-2 does 
not suppress H2S-induced elevation in [Ca2+]i. Conversely, CSE inhibition prevents VEGF-induced 
intracellular Ca2+ movements and angiogenesis in Ea.hy926 cells, whereas it is ineffective in EPCs. 
Therefore, H2S is central to the onset of the pro-angiogenic Ca2+ signals promoted by VEGF in mature 
endothelial cells. 
H2S-induced Ca2+ signals in human endothelial cells 
 5 
2. Materials and Methods 
 
2.1 Ea.hy926 cell culture 
The HUVEC-derived cell line Ea.hy926 was kindly provided by Dr. Livia Visai (Department of 
Molecular Medicine, University of Pavia) at passages >45. Cells were grown in DMEM containing 
15% FCS, 50 units/ml penicillin, 2 mM/ml L-glutamine, 50 μg/ml streptomycin and were maintained at 
37 °C in 5% CO2 atmosphere.  
 
2.2 Isolation and cultivation of endothelial progenitor cells 
Blood samples (40 mL) were obtained from healthy human volunteers aged from 22 to 28 years 
old. The Institutional Review Board at “Istituto di Ricovero e Cura a Carattere Scientifico Policlinico 
San Matteo Foundation” in Pavia approved all protocols. Informed consent was obtained and all 
procedures were performed according to the Declaration of Helsinki. Among the different subtypes of 
EPCs described in literature, we focussed on the so-called endothelial colony forming cells (ECFCs), 
which truly belong to the endothelial phenotype, organize into bidimensional capillary-like networks 
when plated on Matrigel, and form patent vessels in vivo [23, 29]. To isolate ECFCs, mononuclear 
cells (MNCs) were separated from peripheral blood (PB) by density gradient centrifugation on 
lymphocyte separation medium for 30 min at 400g and washed twice in EBM-2 with 2% FCS. A 
median of 36 x 106 MNCs (range 18-66) were plated on collagen-coated culture dishes (BD 
Biosciences) in the presence of the endothelial cell growth medium EGM-2 MV Bullet Kit (Lonza) 
containing endothelial basal medium (EBM-2), 5% foetal bovine serum, recombinant human (rh) EGF, 
rhVEGF, rhFGF-B, rhIGF-1, ascorbic acid and heparin, and maintained at 37°C in 5% CO2 and 
humidified atmosphere. Discard of non-adherent cells was performed after 2 days; thereafter medium 
was changed three times a week. The outgrowth of endothelial colonies from adherent MNCs was 
characterized by the formation of a cluster of cobblestone-appearing cells [33, 34]. That ECFC-derived 
colonies belonged to endothelial lineage was confirmed as described in [33] and [34]. 
 
2.3 Solutions 
Physiological salt solution (PSS) had the following composition (in mM): 150 NaCl, 6 KCl, 1.5 
CaCl2, 1 MgCl2, 10 Glucose, 10 Hepes. In Ca2+-free solution (0Ca2+), Ca2+ was substituted with 2 mM 
NaCl, and 0.5 mM EGTA was added. Solutions were titrated to pH 7.4 with NaOH. The osmolality of 
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the extracellular solution, as measured with an osmometer (Wescor 5500, Logan, UT), was 300-310 
mmol/kg. 
 
2.4 [Ca2+]i measurements 
The cells were loaded with 4 µM fura-2 acetoxymethyl ester (fura-2/AM; 1 mM stock in 
dimethyl sulfoxide) in PSS for 1 hour min at room temperature. After washing in PSS, the coverslip 
was fixed to the bottom of a Petri dish and the cells observed by an upright epifluorescence Axiolab 
microscope (Carl Zeiss, Oberkochen, Germany), usually equipped with a Zeiss ×40 Achroplan 
objective (water-immersion, 2.0 mm working distance, 0.9 numerical aperture). The cells were excited 
alternately at 340 and 380 nm, and the emitted light was detected at 510 nm. A first neutral density 
filter (1 or 0.3 optical density) reduced the overall intensity of the excitation light and a second neutral 
density filter (optical density=0.3) was coupled to the 380 nm filter to approach the intensity of the 340 
nm light. A round diaphragm was used to increase the contrast. The excitation filters were mounted on 
a filter wheel (Lambda 10, Sutter Instrument, Novato, CA, USA). Custom software, working in the 
LINUX environment, was used to drive the camera (Extended-ISIS Camera, Photonic Science, 
Millham, UK) and the filter wheel, and to measure and plot on-line the fluorescence from 10-15 
rectangular “regions of interest” (ROI) enclosing 10-15 single cells. Each ROI was identified by a 
number. Since cell borders were not clearly identifiable, a ROI may not include the whole EPC or may 
include part of an adjacent EPC. Adjacent ROIs never superimposed. [Ca2+]i was monitored by 
measuring, for each ROI, the ratio of the mean fluorescence emitted at 510 nm when exciting 
alternatively at 340 and 380 nm (shortly termed "ratio"). An increase in [Ca2+]i causes an increase in 
the ratio [35, 36]. Ratio measurements were performed and plotted on-line every 3 s. The experiments 
were performed at room temperature (22°C). All the data have been collected from EPCs isolated from 
the peripheral blood of at least three healthy volunteers (EPCs) or three different coverslips of 
Ea.hy926 cells. Statistical comparisons were made by using One way Anova. P<0.05 was considered 
significant. 
 
2.5 Proliferation assay on Ea.hy926 cells 
Ea.hy926 cells were plated in DMEM 15% FCS in a 96-well culture plate (0.05*104 cells/well) 
for 24 hours, and then starved in DMEM 0% FCS for 48 hours. Cells were then incubated with 
treatments dissolved in DMEM 0% for 72 hours and proliferation rate was assessed with the 
colorimetric kit CellTiter 96 AQueous One Solution (Promega, USA) and absorbance was revealed at 
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490 nm in a microplate reader (Bio-Rad) after 3 hours of incubation. Cells treated with PAG (5 mM) 
were pre-incubated for 30 minutes before adding the other treatments. Experiments were performed in 
triplicate. 
 
2.6 In vitro wound healing assay 
Cells were seeded in a 24-well culture plate (4.5*104 cells/well) for 48 hours to reach the 
confluence, and then starved in DMEM 0% FCS for 6 hours. Motility assay was performed generating 
a wound in confluent cellular monolayers scraping with a P10-pipette tip. Floating cells were removed 
by wash in PBS solution, and monolayers were treated with test conditions (in duplicate). Cells treated 
with PAG 5mM were pre-incubated for 30 minutes before adding the other treatments. Experiments 
were performed using a Nikon Eclipse Ti (Nikon Corporation, Tokio, Japan) inverted microscope 
equipped with an incubator to keep cells at 37°C and 5% CO2. Images were acquired at 2 hour time 
intervals using a Nikon Plan 4X/0.10 objective and a CCD camera. MetaMorph software (Molecular 
Devices, Sunnyvale, CA, USA) was used to acquire images. All treatments were dissolved in DMEM 
0% and experiments were performed in triplicate. 
 
2.7 EPC Proliferation assay 
1x105 ECFC-derived cells (1st passage) were plated in 30 mm collagen treated dishes in EGM-
2 MV medium with or without 5 mM PAG [34, 37]. Cultures were incubated at 37°C (in 5% CO2 and 
humidified atmosphere) and cell growth assessed every day until confluence was reached in the control 
cultures (0 mM PAG). At this point, cells were recovered by trypsinization from all dishes and the cell 
number assessed by counting in a haemocytometer. The percentage of growth inhibition by the drug 
was calculated by dividing the total number of cells obtained in presence of 5 mM PAG by the number 
of cells in control experiments and multiplying the ratio by 100.  
 
2.8 Chemicals  
Fura-2/AM was purchased from Molecular Probes (Molecular Probes Europe BV, Leiden, The 
Netherlands). N-(4-[3,5-Bis(trifluoromethyl)-1H-pyrazol-1-yl]phenyl)-4-methyl-1,2,3-thiadiazole-5-
carboxamide (BTP-2) was provided by Calbiochem (La Jolla, CA, USA). All other chemicals were 
obtained from Sigma. H2S was administered in the form of sodium hydrosulfide (NaHS), the most 
commonly employed H2S donor. When dissolved in neutral solution, NaHS dissociates to Na+ and HS-, 
which then reacts with H+ to yield H2S. Free H2S gas accounts for approximately 30-33% of a molar 
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concentration of NaHS at 20°C, while the Na+ content and the pH of the solution are not appreciably 
altered [1]. 
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3. Results 
 
3.1 NaHS elicits intracellular Ca2+ signals in Ea.hy926 cells 
The Ca2+ response to NaHS was first assessed in Ea.hy926 cells: this is a widely employed 
hybrid cell line established by fusing HUVEC with the A549/8 human lung carcinoma cell line and 
possesses the angiogenic features of differentiated endothelial cell. Ea.hy926 cells did not display any 
detectable increase in [Ca2+]i when NaHS concentration ([NaHS]) was maintained below a threshold 
level of 1 PM (not shown). The percentage of responding cells augmented at [NaHS] t1 PM and 
displayed a bell-shaped dose-response relationship with a peak at 30 PM (Fig. 1A). The amplitude of 
the Ca2+ signal manifested a rather complex behaviour, whereas the Ca2+ peak increased when [NaHS] 
was raised from 1 PM up to 10-30 PM, decreased for further elevations to 50-100 PM, and finally 
augmented again when the donor was administrated at 200 PM (Fig. 1B). Figure 1C depicts 
representative traces of the Ca2+ signals induced in Ea.hy926 cells by NaHS at 1, 30, and 100 PM. 
Thirty PM NaHS caused an immediate, but slow elevation in [Ca2+]i which was followed by a slow 
phase of recovery to the baseline. However, a complete decay of the Ca2+ signal was barely achieved 
even after agonist washout; this feature has also been observed in primary cultures of endothelial cells 
dissociated from saphenous vein (SVECs) [38] and in B-TECs [21] and prevented us from probing the 
effect of consecutive applications of NaHS. Overall, there results show that Ea.hy926 cells are a useful 
tool to investigate the signal transduction machinery shaping the Ca2+ response to H2S in mature 
endothelial cells. All the subsequent experiments were carrying out by using NaHS at 30 PM, which is 
the dose activating the larger number of Ea.hy926 cells (Fig. 1A). 
 
3.2 The Ca2+ response to NaHS is mediated by inositol-1,4,5-trisphosphate-dependent Ca2+ 
release 
In order to assess the role played by extracellular Ca2+ entry and intracellular Ca2+ release in 
generating the Ca2+ response to NaHS, external Ca2+ was removed from the bath (0Ca2+). Under such 
conditions, the H2S donor caused an increase in [Ca2+]i (Fig. 2A), whose amplitude (Fig. 2C) and time-
to-peak (TTP) (Fig. 2D) were not different from those recorded in the presence of Ca2+. This result 
strongly suggests that Ca2+ influx plays a minor role, if any, in shaping NaHS-induced Ca2+ signals. 
This issue was further elucidated by assessing the contribution of SOCE. Store-dependent Ca2+ inflow 
mediated by the physical interaction between Stim1 and Orai1 is the major Ca2+-permeable pathway 
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activated in HUVEC after physiological depletion of intracellular Ca2+ reserves [31]. However, when 
Ea.hy926 cells were pre-treated with BTP-2 (20 PM; 20 min), a widely employed SOCE inhibitor [28, 
29], the Ca2+ response to NaHS was not significantly altered as respect to control cells (Fig. 2B-2D). 
Collectively, these results indicate that NaHS-induced Ca2+ signaling requires intracellular Ca2+ 
mobilization in Ea.hy926 cells. The endoplasmic reticulum contains the main Ca2+ pool in mature 
endothelial cells and discharges Ca2+ in response to endogenous InsP3 synthesized after phospholipase 
C (PLC) activation [27]. The contribution of the PLC/InsP3 signalling pathway in the signal 
transduction cascade leading to NaHS-induced [Ca2+]i elevations was ascertained by first pre-
incubating the cells with (1-(6-((17β-3-methoxyestr-1,3,5(10)-trien-17-yl)amino)-hexyl)-1H-pyrrole-
2,5-dione) (U73122; 10 PM), a popular PLC antagonist [35, 36]. This manoeuvre reversibly suppressed 
the Ca2+ response to NaHS in 120 out of 120 cells (100%) (Fig. 3A). Likewise, 2-nitro-4-
carboxyphenyl-N,N-diphenylcarbamate  (NCDC; 50 PM), another structurally unrelated PLC inhibitor 
[39], hindered NaHS-evoked increase in [Ca2+]i in 36 out of 40 cells (90%) (Fig. 3B). However, the 
intracellular Ca2+ activity did not resume upon NCDC removal from the bath (Fig. 3B). Next, the 
InsP3-sensitive Ca2+ store was depleted by exposing the cells to the selective SERCA inhibitor, 
cyclopiazonic acid (CPA) (10 PM), in 0Ca2+ to prevent SOCE [35, 39]. Under such conditions, ATP 
(100 PM), that mobilizes Ca2+ from InsP3Rs in HUVEC [31], did not cause any detectable increase in 
[Ca2+]i in 57 out of 57 cells (100%). Similarly, the subsequent administration of NaHS failed to 
augment intracellular Ca2+ levels (Fig. 3C). Consistently, 2-aminoethoxydiphenyl borate (2-APB; 50 
PM), a widely employed InsP3R blocker, abrogated the Ca2+ response to NaHS in 121 out of 121 cells 
(100%) (Fig. 3D). Taken together, these data show that the NaHS activates PLC to liberate 
intraluminally stored Ca2+ in Ea.hy926 cells. 
 
3.3 Interaction between H2S and VEGF in the modulation of intracellular Ca2+ homeostasis 
in Ea.hy926 cells 
Recent evidence has indicated VEGFR-2 as the long-sought receptor for H2S-mediated 
signalling in endothelial cells [18]. Therefore, we challenged the hypothesis that H2S-evoked [Ca2+]i 
elevations in Ea.hy926 cells are driven by VEGFR-2 by first pre-incubating the cells with genistein (10 
PM, 10 min), a protein tyrosine kinase inhibitor [39]. Figure 4A shows that this treatment reversibly 
abolished the NaHS-induced intracellular Ca2+ wave in 82 out of 89 cells (92.1%). However, 1,3-
Dihydro-3-[(3,5-dimethyl-1H-pyrrol-2-yl)methylene]-2H-indol-2-one (SU5416; 10 PM, 30 min), a 
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specific antagonist of VEGFR-2 [18], did not affect NaHS-evoked intracellular Ca2+ signals in 
Ea.hy926 cells (Fig. 4B). More specifically, neither the fraction of responding cells (70% vs. 65% in 
not treated cells) nor the amplitude of the elevation in [Ca2+]i (0.153r0.008 vs. 0.149r0.007 in not 
treated cells, n=65 and 72, respectively) were significantly affected by SU5416. In order to confirm that 
SU5416 was able to interfere with intracellular Ca2+ signalling in Ea.hy926 cells, we first assessed the 
Ca2+ response to VEGF (10 ng/ml). As shown in Fig. 4C (black tracing), VEGF augmented 
intracellular Ca2+ levels in 49 out of 78 (62.8%) control cells. Conversely, the pre-treatment with 
SU5416 (10 PM, 30 min) irreversibly abolished VEGF-induced increase in [Ca2+]i in 27 out of 28 cells 
(96.4%) (grey tracing Fig. 4C). Nevertheless, the pharmacological blockade of H2S synthesis with PAG 
(5 mM, 30 min), a specific CSE inhibitor [21, 32], prevented the Ca2+ response to VEGF (10 ng/ml) in 
69 out of 74 cells (93.2%) (Fig. 4D). The Ca2+ response to the growth factor immediately resumed 
upon washing PAG out of the bath (Fig. 4D). Therefore, H2S does not target VEGFR-2 to produce an 
increase in [Ca2+]i in Ea.hy926 cells, but VEGFR-2 recruits CSE to ignite Ca2+ signals in these cells. 
 
3.4 Endogenous H2S is required for Ea.hy926 cells proliferation and migration 
In order to evaluate whether and how H2S-mediated, VEGF-induced Ca2+ signals impact on 
Ea.hy926 cells-dependent angiogenesis, we performed proliferation and in vitro migration experiments. 
The selective inhibition of CSE with PAG (5 mM, 72 hours) induced a significant reduction in 
Ea.hy926 proliferation induced by VEGF (10 ng/ml), while NaHS 30 µM did not affect cell growth 
(Fig. 5A). Figure 5B reports the percentage of migration in wound healing experiments after 8 hours of 
treatment. As expected, we observed a pro-migratory response induced by VEGF (10 ng/ml), but this 
effect was prevented by pre-incubating the cells with PAG (5 mM, 30 min), thereby suggesting that the 
endogenous production of H2S is involved in the pro-angiogenic response to VEGF. Conversely, 
exogenous administration of H2S (NaHS, 30 µM) was not able to affect Ea.hy926 cell migration. 
Overall, these data strongly suggest that, although H2S alone is not able to stimulate Ea.hy926 cell 
proliferation and migration, VEGF utilizes this gasotransmitter to generate pro-angiogenic Ca2+ signals. 
  
3.5 NaHS does not reproducibly generate intracellular Ca2+ signals in endothelial progenitor 
cells 
Finally, we analyzed the Ca2+ response to NaHS in circulating EPCs, which are extremely 
useful to investigate the basic features of Ca2+ signalling in endothelial progenitors [23, 28, 29, 40, 41] 
A recent series of papers from our group has indeed demonstrated that Ca2+ signaling plays a key role 
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in driving EPC proliferation and migration [33, 34, 36, 40]. However, we found that NaHS induces an 
increase in [Ca2+]i in a modest percentage of cells when administrated at doses ranging from 1 PM to 50 
PM (Fig. 6A). The fraction of responding cells slightly, but significantly, increases when [NaHS] is 
raised up to 250 PM. No Ca2+ signal was observed when EPCs are challenged with higher [NaHS] (Fig. 
6A). Interestingly, the average amplitude of NaHS-induced Ca2+ signals remained constant whatever 
the concentration of the donor we employed (Fig. 6B). Figure 6C illustrates the typical elevation in 
[Ca2+]i induced by NaHS in EPCs: a rapid Ca2+ spike followed by a plateau phase of intermediate 
magnitude onto which rapid Ca2+ spikes could be overlapped. Intracellular Ca2+ levels were restored 
when NaHS was washed out from the bath. The low fraction of cells sensitive to NaHS did not permit 
us to reliably investigate the mechanisms underlying Ca2+ signalling in EPCs. Nevertheless, we sought 
to assess whether H2S underpins the pro-angiogenic Ca2+ oscillations elicited by VEGF in these cells 
[35, 36]. Unlike Ea.hy926 cells, PAG (5 mM, 30 min) did not significantly impair either the percentage 
of EPCs displaying Ca2+ oscillations in response to VEGF (10 ng/ml) (Fig. 6D and Fig. 6E) or the rate 
of VEGF-induced proliferation (Fig. 6C). Overall, these results strongly suggest that H2S is not 
involved in the generation of pro-angiogenic Ca2+ signals in human endothelial progenitors. 
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4. Discussion 
 
Hydrogen sulphide has recently been described as a key signalling gasotransmitter in vascular 
endothelium [2, 3]. H2S may promote endothelial proliferation and migration, thus stimulating 
angiogenesis and restoring local blood perfusion in several rodent models of hindlimb ischemia [17, 
22]. A growing number of studies established a tight and finely tuned interplay between H2S and 
VEGF. The growth factor may activate endothelial cells by inducing H2S synthesis and, viceversa, H2S 
may elevate VEGF levels and stimulate VEGFR-2 to trigger its downstream phosphorylative cascades. 
Ca2+ signalling serves a central role in angiogenesis and stands amid the network of molecular 
mechanisms engaged by H2S in mature endothelial cells [4, 23, 26, 41]. Therefore, we undertook the 
present investigation: 1) to compare the Ca2+ response between Ea.hy926 cells, a widely employed 
mature endothelial cell line and endothelial committed progenitors; 2) to assess whether VEGFR-2 
contributes to shape the Ca2+ response to H2S and, viceversa, whether H2S triggers VEGF-induced Ca2+ 
signals; and 3) to ascertain whether the pharmacological abrogation of H2S synthesis interferes with the 
pro-angiogenic activity of VEGF in both endothelial cell types. 
 
While a previous report from our group showed that H2S-evoked Ca2+ signals could be involved 
in VEGF-elicited motility in tumour endothelium [21], herein we dissected the Ca2+ response to this 
gasotransmitter in the HUVEC-derived endothelial cell line EA.hy926. The following pieces of 
evidence indicate that H2S-evoked Ca2+ signals are patterned by intracellular Ca2+ release through 
InsP3Rs. First, NaHS evoked similar Ca2+ signals both in the presence and in the absence of 
extracellular Ca2+. Likewise, H2S-induced increase in [Ca2+]i was not affected when SOCE, the most 
important pathway for Ca2+ entry in HUVECs [31], was inhibited with BTP-2 [23, 28]. Therefore, H2S-
elicited [Ca2+]i elevation primarily requires intracellular Ca2+ mobilization. Second, depleting the InsP3-
sensitive Ca2+ pool with CPA prevented the subsequent Ca2+ response to NaHS. Third, the 
pharmacological blockade of the PLC/InsP3 signalling pathway with either U73122/NCDC or 2-APB 
suppressed NaHS-induced Ca2+ waves. Therefore, H2S stimulates PLC, perhaps via S-sulphydrilation 
[4], to synthesize InsP3 and mobilize intraluminally stored Ca2+ in Ea.hy926 cells. Ryanodine receptors 
are seemingly not expressed in these cells [42], so that their contribution to the H2S-induced Ca2+ 
signals is unlikely. This mechanism is strikingly different from that depicted in B-TECs, HMVECs and 
rat aortic endothelial cells, which heavily depend on extracellular Ca2+ entry to produce a Ca2+ response 
to NaHS [4, 21, 32]. Conversely, H2S utilizes InsP3Rs and ryanodine receptors to shape intracellular 
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Ca2+ signals in SVECs [38], thereby suggesting that the molecular mechanisms recruited by this 
gasotransmitter to modulate endothelial Ca2+ homeostasis depend on both species and vessel type, 
which may dictate the pattern of expression of the components of the Ca2+ machinery [27]. Our data are 
consistent with those recently described in HeLa cells, where the slow H2S-release donor morpholin-4-
ium-4-methoxyphenyl-(morpholino)-phosphinodithioate (GYY4137) increases [Ca2+]i by up-regulating 
InsP3R1 and InsP3R2 [43]: however, our results do not fit with parallel findings in mouse airway 
smooth muscle cells (ASMCs) [44]. Herein, exogenous H2S reduces InsP3Rs to repress InsP3-
dependent Ca2+ release and the consequent muscle relaxation [44]. The Authors of the study concluded 
that a reducing ER environment leads the luminal protein ERp44 to bind to and inhibit InsP3Rs. 
However, this process requires a strong drop in ER Ca2+ levels [45]. Interestingly, the inhibitory effect 
of H2S in ASMCs has been observed upon a first InsP3-dependent ER depletion in the absence of the 
gasotransmitter; this initial response might have caused a local reduction in intraluminal Ca2+ nearby 
InsP3Rs, thereby rendering them more sensitive to the reducing conditions associated to H2S 
stimulation. Conversely, both in our present study and others [38] the InsP3-dependent Ca2+ pool was 
not depleted before presenting the cells with H2S which might explain the differences with the study on 
ASMCs [44]. 
 
We further attempted to decipher the signaling pathway upstream PLC recruitment by H2S. A 
recent study showed that H2S caused VEGFR-2 autophosphorylation in Tyr1175, which is required to 
stimulate PI3-K and Akt in HUVECs [18]. First, we demonstrated that genistein reversibly prevented 
the onset of the Ca2+ response to Ea.hy926 cells, thus indicating the involvement of PLCJ in H2S-
induced Ca2+ signals [39]. However, SU5416, a popular VEGFR-2 inhibitor that prevents PI3-K and 
Akt activation in HUVECs [18], did not interfere with the Ca2+ response to NaHS. These observations 
suggest that H2S targets VEGFR-2 to promote the phosphorylation of PI3-K and Akt, but not the 
recruitment of PLCJ. An alternative explanation is that PLCJ is enlisted by Src family kinases [46], 
which are non-receptor tyrosine kinases involved in H2S signaling [47]. A different scenario implies 
that H2S activates a distinct PLC isoform, such as the E subtype, and that genistein-induced inhibition 
of InsP3-dependent Ca2+ mobilization rather reflects the blockade of InsP3R phosphorylation by the 
non-receptor tyrosin kinase, Fyn [48]. Although H2S stimulates intracellular Ca2+ release without 
activating VEGFR-2, VEGF recruits CSE-dependent H2S production to increase [Ca2+]i in Ea.hy926 
cells: consistently, the pharmacological blockade of the enzyme prevented the Ca2+ response to NaHS. 
This result concurs with our previous observations that VEGF-induced elevation in [Ca2+]i is inhibited 
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by pre-incubating B-TECs with PAG [21]. In addition, this finding sheds more light on the molecular 
mechanisms whereby CSE silencing prevents the pro-angiogenic effects of VEGF [19, 20]. Indeed, 
PAG inhibited both Ea.hy926 cell proliferation and migration, indicating that H2S-mediated 
intracellular Ca2+ signals control VEGF-dependent angiogenesis. Future studies will have to unveil 
whether the intracellular events triggered by VEGF in endothelial cells require the concomitant H2S-
dependent increase in [Ca2+]i or serve as two parallel, yet not redundant, signaling pathways. It should, 
however, be pointed out that H2S per se failed to affect the biological activity of Ea.hy926 cells. This 
result is consistent with previous findings by Wang’s group, who demonstrated that the administration 
of NaHS alone influence Ea.hy926 tube formation only in hypoxic, but not in normoxic conditions 
[49]. Therefore, albeit both intracellular Ca2+ waves and ERK and PI-3K/Akt may be engaged by H2S, 
they are not sufficient to activate the pro-angiogenic program in these cells, which require the 
participation of additional mechanisms recruited by VEGF. 
 
Once characterized the basic underpinnings of the Ca2+ response to NaHS in a well established 
model of mature endothelial cells, we turned to their more immature progenitors. Endothelial 
progenitor cells are released from either bone marrow or the arterial wall to replace senescent or 
dysfunctional endothelial cells, thereby restoring blood flow upon occlusion of feeding arteries in the 
heart, in peripheral limbs and in the brain [23, 24, 40, 41]. A series of studies from our group has 
demonstrated that the concerted interplay between InsP3-dependent Ca2+ mobilization and SOCE 
underlies the pro-angiogenic effect of VEGF in circulating human EPCs [33-36]. A recent study has 
unveiled that H2S regulate human bone marrow-derived mesenchhymal stem cells (BMMSCs) self-
renewal and osteogenic differentiation by inducing Ca2+ entry through TRPV3 and TRPV6 [50]. Unlike 
Ea.hy926 cells and BMMSCs, we found that NaHS induces a detectable Ca2+ signal only in a modest 
fraction of circulating EPCs. While the percentage of responding cells slightly increases by augmenting 
[NaHS] from 5 µM up to 250 µM, the amplitude of the Ca2+ peak is unchanged over this range of 
stimulus intensities. No elevation in [Ca2+]i could be evoked by further raising [NaHS]. Therefore, 
increasing [NaHS] does not lead to an enhancement in the magnitude of the Ca2+ response, but to the 
recruitment of more cells. This rather unusual dose-response relationship is peculiar to human EPCs, 
since the amplitude of the Ca2+ response increases with the extent of NaHS stimulation in B-TECs [21], 
human microvascular endothelial cells (HMVECs) [21], SVECs [38], and Ea.hy926 cells (present 
study). Assuming that the Ca2+ response in EPCs is shaped by the PLCJ/InsP3 pathway described for 
Ea.hy926 cells, we speculate that higher doses of NaHS release more H2S, thereby augmenting the 
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probability to activate its underlying signalling cascade in a larger number of cells. However, the H2S-
sensitive PLCJ pool must be limited and already saturated at low NaHS concentrations. This feature 
would explain why the percentage of activated cells, but not the magnitude of the [Ca2+]i elevation, 
increases up to stimulation with 250 PM NaHS. The absence of any detectable Ca2+ signal at 500 PM 
NaHS supports previous findings obtained on primary cultures of rat hippocampal astrocytes, where the 
Ca2+ response to NaHS was significantly reduced at doses higher than 320 PM [51]. This same range of 
NaHS doses suppresses glutamatergic synaptic transmission in rat hippocampus [52]. Similarly, it is 
conceivable that 500 PM is such a high [NaHS] concentration to be toxic for Ea.hy926, which might 
explain why it fails to induce an increase in [Ca2+]i. An additional difference between endothelial 
committed progenitors and mature endothelial cells is the lower sensitivity of EPCs to the 
gasotransmitter. The proportion of cells displaying a robust Ca2+ activity in the presence of NaHS is 
dramatically higher in B-TECs [21], HMVECs [21], SVECs [38], and Ea.hy926 cells (present study). 
Consistent with these data, the pharmacological CSE abrogation with PAG affected neither VEGF-
induced Ca2+ oscillations nor proliferation in human EPCs, suggesting that H2S plays a little role, if 
any, in the pro-angiogenic response to the growth factor. However, we cannot rule out the impact of 
H2S on alternative signalling pathways, such as KATP channels, PI-3K, and MAPK [3]. The full 
comprehension of the molecular mechanisms whereby H2S engages PLC to trigger Ca2+ release 
through InsP3Rs in Ea.hy926 cells will permit to understand why it fails to do so in EPCs. 
 
In conclusion, this study contributes to elucidate the complex network of signaling pathways 
recruited by H2S in endothelial cells. First, H2S evokes a robust Ca2+ activity in Ea.hy926 cells, a 
human umbilical vein endothelial cell line which is widely employed to investigate in vitro 
angiogenesis, but not in more immature endothelial committed progenitors. Second, H2S mobilizes the 
intracellular Ca2+ pool by likely activating PLCJ and InsP3 release. Third, CSE contributes to trigger 
the pro-angiogenic Ca2+ response to VEGF in Ea.hy926 cells, but not in EPCs. It has long been known 
that VEGF-induced Ca2+ signals in human umbilical vein endothelium are ignited upon the activation 
of the PLCJ/InsP3-dependent signalling axis [53]. Our results suggest that, in addition to direct 
phosphorylation by VEGFR-2, PLCJ might be recruited to the plasma membrane by the concomitant 
synthesis of H2S. Indeed, under physiological conditions, H2S could induce a sub-membranal Ca2+ 
elevation to facilitate the activation of this Ca2+-dependent enzyme. This scenario is subtly different 
from that envisaged by other authors and will deserve particular attention by future studies. Indeed, it 
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has recently been proposed that VEGF causes H2S synthesis by discharging intracellular Ca2+ to 
stimulate the Ca2+-sensitive CSE [19]. The results described elsewhere [21] and in the present study 
might lead to the re-evaluation of this hypothesis. 
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5. Figure legends 
 
Figure 1. NaHS is a reliable activator of intracellular Ca2+ signals in Ea.hy926 cells. A, 
percentage of Ea.hy926 cells exhibiting an elevation when stimulated with increasing doses of NaHS. 
B, dose-response relationship of the Ca2+ response to NaHS in Ea.hy926 cells. Data are expressed as 
meanrSE. In both Panel A and Panel B, for each concentration, n ranged from 172 to 435 cells 
recorded from 3-5 independent coverslips. C, representative tracing of the increase in [Ca2+]i elicited by 
three different doses of NaHS in Ea.hy926 cells. *P<0.05 as respect to 10, 30 and 200 µM; **P<0.05 
as respect to 10, 30 and 200 µM. 
 
Figure 2. Ca2+ entry does not trigger the Ca2+ response to NaHS in Ea.hy926 cells. A, 
removal of extracellular Ca2+ (0 Ca2+) does not prevent the onset of NaHS-induced Ca2+ signals in 
Ea.hy926 cells. NaHS has been applied at 30 PM. B, 30 min pre-incubation with 20 PM BTP-2, a 
powerful inhibitor of store-operated Ca2+ channels, did not interfere with the Ca2+ response to 20 PM 
BTP-2 C, meanrSE of the amplitude of NaHS-evoked increases in [Ca2+]i in the absence of 
extracellular Ca2+ or in the presence of 20 PM BTP-2. D, meanrSE of the time to peak of NaHS-
evoked [Ca2+]i increases in the absence of extracellular Ca2+ or in the presence of 20 PM BTP-2. 
 
Figure 3. Phospholipase C and inositol-1,4,5-trisphosphate receptors shape the elevation in 
[Ca2+]i induced by NaHS in Ea.hy926 cells. The inhibition of PLC with either U73122 (10 PM) (A) or 
NCDC (50 PM) (B) prevented the Ca2+ response to NaHS (30 PM) in Ea.hy926 cells. C, the depletion 
of the InsP3-sensitive Ca2+ pool with cyclopiazonic acid (20 PM) in 0Ca2+ abrogated NaHS-induced 
Ca2+ signals. NaHS has been applied at 30 PM. D, the inhibition of InsP3Rs with 2-APB (50 PM) 
suppressed the increase in [Ca2+]i elicited by NaHS (30 PM). 
 
Figure 4. The relationship between H2S and VEGF in modulating intracellular Ca2+ signals 
in Ea.hy926 cells. A, genistein (10 PM) prevented the onset of NaHS-induced Ca2+ signals in Ea.hy926 
cells. NaHS has been applied at 30 PM. B, pre-incubation with SU5416 (10 PM, 30 min), a blocker of 
VEGFR-2 activity, did not affect the Ca2+ response to NaHS (30 PM). C, VEGF-evoked elevation in 
[Ca2+]i was inhibited by SU5416 (10 PM, 30 min (grey tracing), while it occurred in control cells 
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(black tracing). C, VEGF-induced Ca2+ signals were abrogated by pre-treating the cells with PAG (5 
mM, 30 min), a selective CSE inhibitor. 
 
Figure 5. Effects of exogenous and endogenous H2S on Ea.hy926 cell proliferation and 
migration. A, Pre-incubation with the selective CSE inhibitor PAG (5 mM for 30 min), significantly 
reduced cell growth induced by VEGF (10 ng/ml, 72 hours). Absorbance at 490 nm is reported on Y 
axis. B, Histograms report the percentage of migration evaluated in wound healing experiments at 8 
hours of treatment. Pre-incubation with PAG (5 mM, 30 min) reduced cells migration induced by 
VEGF 10 ng/ml (DMEM 0% was used as Ctl). Conversely, NaHS (30 µM) did not affect cell 
migration. All data are representative of three independent experiments. *P < 0.05; ** p < 0.01 
compared to VEGF 10 ng/ml. 
 
Figure 6. NaHS is not a powerful stimulator of Ca2+ signalling in human endothelial 
progenitor cells. A, fraction of EPCs displaying a detectable increase in [Ca2+]i when challenged with 
increasing doses of NaHS. For each concentration, n ranged between 50 and 120 cells isolated from 
three different healthy donors. B, meanrSE of the amplitude of the elevations in [Ca2+]i induced by 
NaHS in ECFCs. C, representative tracing of the Ca2+ signals elicited by 1 PM NaHS in human EPCs. 
D, meanrSE of the percentage of EPCs responding to VEGF (10 ng/ml) with Ca2+ oscillations in the 
absence and presence of PAG (5 mM). The numbers of cells computed for the statistical analysis were 
equal to 151 and 89, respectively, from three separate donors. E, sample traces of intracellular Ca2+ 
oscillations evoked by VEGF (10 ng/ml) in the presence (black tracing) and absence (grey tracing) of 
PAG (5 mM). *P<0.05. F, meanrSE of EPCs counted after three days in culture in the presence of 
EBM-2 (which served as control), EBM-2 + VEGF (10 ng/ml), and EBM-2 + VEGF (10 ng/ml) + PAG 
(5 mM). The results are representative of three different experiments conducted on cells harvested from 
three different donors. 
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Dear Referee #1, 
 
Thank you very much for your nice comments on our manuscript entitled “Hydrogen 
sulphide triggers VEGF-induced intracellular Ca2+ signals in human endothelial cells but not in 
their immature progenitors”. We amended the manuscript according to your suggestions and 
addressed all you criticisms you raised. We do believe that your suggestions did improve the quality 
of the paper and do hope that you will now find it suitable for publication on Cell Calcium. 
 
Major comments 
It was reported that NaHS stock solution can by oxidized by O2 under air to polysulfides 
(ABS at 290 nm), which can have biological effects (see Yuka Kimura, at al. FASEB J. 2013: † doi: 
10.1096/fj.12-226415), and the commercial product, NaHS, mostly contain impurities and/or 
oxidation products, those can have also biological effects. 
In this context, it is not clear how your H2S stock solution was prepared, history of the 
solution and handling of the samples.   
How was H2S concentration determined? (See publication - + Supplementary data Greiner 
R. et al. ARS 2013). 
 
This assertion is certainly true and we thank you for the advice to illustrate the preparation 
of NaHS stock and final solutions. The use of NaHS in the current experiments does not only 
depend on our past experience with this H2S donor. We aimed at investigating for the first time the 
relationship, if any, between H2S, Ca2+ signalling and angiogenesis. Most of the studies conducted 
to assess whether H2S promotes angiogenesis both in vitro (Altaany et al., J Cell Mol Med 2013; 
17(7):879-88; Cai et al., Cardiov Res 2007; 76:29-40; Coletta et al., Proc Natl Acad Sci U S A 
2012; 109(23):9161-6; Papapetropoulos et al., Proc Natl Acad Sci USA 2009; 106(51):21972-7; tao 
et al., Antioxid Redox Signal 2013; 19(5):448-64) and in vivo (Coletta et al., Proc Natl Acad Sci 
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USA 2012; 109(23):9161-6; Papapetropoulos et al., Proc Natl Acad Sci USA 2009; 106(51):21972-
7; Qipshidze et al., Int J Biol Sci 2012; 8:(4), 430-441; Wang et al., Clin Exp Pharmacol 
Physiol 2010; 37(7):764-71), utilized NaHS as a donor. Therefore, we reasoned that it was more 
appropriate to exploit this same compound in our experiments. 
Prof. Tanzi’s comments here. 
 
 
Minor comments 
1.) Can you conclude from your study that RyR calcium channel is not involved in your observed 
effects? 
 
As now discussed on Page 13 Line 28, one earlier report suggests that this endothelial cell 
line does not express ryanodine receptors. 
 
2.) Some abbreviations (e.g. 2-APB page 10) should have full name somewhere. 
 
You are right. We introduced in the text all the full names missing in the previous version of 
the manuscript. 
 
3.) P. 11: Fig. 6A; Can you discuss no effect of NaHS at 500 µM? 
 
Thank you for this suggestion. This issue deserved more attention and we discussed it on 
page 16 Line 4. 
 
4.) Fig. 6B; Can you discuss the same peak amplitude for different NaHS concentrations?  
 
Again, thank you very much for this observation. We discussed this feature on Page 15, Line 
31. 
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5.) Can you include into the discussion some inconsistency of H2S effect on IP3R activity (e.g. 
inhibition effect (Castro-Piedras I, J Physiol. 2013) and your activation effects or others (e.g. L. 
Lencesova, et al. Acta Physiol 2013). 
 
Absolutely so. We discussed this rather interesting point on Page 14, Line 3. 
 
With my kindest regards, 
 
Francesco Moccia, PhD 
Department of Biology and Biotechnology “Lazzaro Spallanzani”,  
University of Pavia,  
Via Forlanini 6, 27100, Pavia, Italy. 
Tel: 0039 0382 987614. 
Fax: 0039 0382 987527.  
E-mail: francesco.moccia@unipv.it  
              Università Degli Studi di Pavia  
Dipartimento di Biologia e 
Biotecnologie “Lazzaro 
Spallanzani”, 
        Sezione di Fisiologia Generale, 
                                              Via Forlanini 6 
                                               27100 Pavia 
                                               Italy 
 4 
Dear Referee #2, 
We were happy to read your comments on our manuscript entitled “Hydrogen sulphide 
triggers VEGF-induced intracellular Ca2+ signals in human endothelial cells but not in their 
immature progenitors”. We amended the manuscript according to your suggestions and addressed 
all you criticisms you raised. We do believe that your suggestions did improve the quality of the 
paper and do hope that you will now find it suitable for publication on Cell Calcium. 
 
Specific points 
*       If VEGF receptor is simultaneously stimulated by its selective agonist and by NaSH 
treatment, are the effects on pro-angiogenic Ca2+ response additive or mutually exclusive? What is 
the dominant mechanism? 
 
Hydrogen sulphide is utilized by VEGF to trigger the Ca2+ response. Therefore, it is a key 
hub in the signalling pathway initiating the pro-angiogenic cascade elicited by this growth factor. If 
VEGF requires hydrogen sulphide to augment intracellular Ca2+ levels, the mitogen and the 
gasotransmitter operate in series rather than in parallel; this implies that their responses are neither 
additive nor mutually exclusive since they target the same machinery (i.e. the PLCJ/InsP3 receptors 
axis) to exert the same effect. Indeed, our preliminary data show that neither the kinetics nor the 
amplitude of the Ca2+ response to VEGF are different when administrated along with NaHS. We 
will be glad to add this data if you require it. 
 
*       Did the Authors consider S-sulphydrilation of specific target as alternative mechanism of 
action of H2S? 
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Thank you for this very interesting observation. Yes, we did it and we address this issue on 
Page 13, Line 27. Moreover, upon request of Referee #1, we discussed the possible effect of InsP3R 
reduction by hydrogen sulphide on Page 14, Line 8. 
 
*       In Materials and Methods the specific statistical approach used for determination difference in 
Fig. 1 and Fig 2 should be indicated.  One way ANOVA is appropriate. 
 
You are absolutely right and we are grateful for this observation. Actuallu, we used One way 
Anova followed by Student’s t-test. 
 
*       Introduction. The authors should insert more information regarding physiological 
cardiovascular effects of H2S, citing original article rather than reviews. 
 
We were happy to follow your advice and to quote the original articles describing the effects 
of hydrogen sulphide on cardiovascular system. In this view, we added more effects exerted by this 
gasotransmitter on vascular endothelial cells. 
 
*       Discussion needs to be strongly reduced. 
 
We shortened the Discussion, but had to address several additional issues upon kind request 
of Referee #1. 
 
*       There are several typos in the text. 
 
Thank you for this observation. We amended all the typos in the text. 
 
With my kindest regards, 
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Francesco Moccia, PhD 
Department of Biology and Biotechnology “Lazzaro Spallanzani”,  
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Tel: 0039 0382 987614. 
Fax: 0039 0382 987527.  
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